122800-01-5

Basic information

• Product Name: 3-AMINO-1-BENZYL-1H-PYRAZOLE-4-CARBONITRILE
• Synonyms: 3-AMINO-1-BENZYL-1H-PYRAZOLE-4-CARBONITRILE
• CAS NO: 122800-01-5
• Molecular Formula: C₁₁H₁₀N₄
• Molecular Weight: 198.23
• Mol File: 122800-01-5.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 444.421°C at 760 mmHg
• Flash Point: 222.578°C
• Appearance: /
• Density: 1.226g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.65
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 3-AMINO-1-BENZYL-1H-PYRAZOLE-4-CARBONITRILE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-AMINO-1-BENZYL-1H-PYRAZOLE-4-CARBONITRILE(122800-01-5)
• EPA Substance Registry System: 3-AMINO-1-BENZYL-1H-PYRAZOLE-4-CARBONITRILE(122800-01-5)

Safety Data

• Hazardous Substances Data: 122800-01-5(Hazardous Substances Data)

Usage

General Description

3-AMINO-1-BENZYL-1H-PYRAZOLE-4-CARBONITRILE, also known as ABPC, is a chemical compound with the molecular formula C12H11N5. It is a pyrazole derivative with a carbonitrile functional group and an amino group attached to the 3-position of the benzyl ring. ABPC is a versatile intermediate used in the synthesis of various pharmaceuticals, agrochemicals, and other organic compounds. It can also be utilized as a building block in the development of new chemical entities with potential biological activities. ABPC is an important chemical in the field of medicinal chemistry and drug discovery due to its structural flexibility and synthetic utility.

InChI:InChI=1/C11H10N4/c12-6-10-8-15(14-11(10)13)7-9-4-2-1-3-5-9/h1-5,8H,7H2,(H2,13,14)

Upstream product

• 16617-46-2 3-Amino-4-cyanopyrazole 
• 100-39-0 benzyl bromide 
• 20570-96-1 benzylhydrazine dihydrochloride 
• 123-06-8 Ethoxymethylenemalononitrile 
• 100-44-7 benzyl chloride 
• 16617-46-2 3-amino-4-cyano-2H-pyrazole 

Downstream Products

• 122800-04-8 1-Benzyl-3-(4-fluoro-2-nitro-phenylamino)-1H-pyrazole-4-carbonitrile 
• 56156-22-0 5-amino-1-benzyl-1H-pyrazole-4-carboxylic acid amide 
• 128691-35-0 3-Amino-1-benzylpyrazol-4-carbonsaeureamid 
• 66077-23-4 C₁₁H₈N₄O₂ 
• 1380347-91-0 tert-butyl [(5S)-2-benzyl-7-hydroxy-6-oxo-4,5,6,7-tetrahydro-2H-pyrazolo[3,4-b]pyridin-5-yl]carbamate 
• 1380347-90-9 2,2,2-trifluoroethyl 3-(1-benzyl-3-nitro-1H-pyrazol-4-yl)-N-(tert-butoxycarbonyl)-L-alaninate 
• 1380349-00-7 (5S)-5-amino-2-benzyl-7-hydroxy-2,4,5,7-tetrahydro-6H-pyrazolo[3,4-b]pyridin-6-one 
• 1380347-88-5 3-(1-benzyl-3-nitro-1H-pyrazol-4-yl )-N-(tert-butoxycarbonyl )-Lalanine 
• 1380481-72-0 C₁₃H₁₄N₄O₄ 
• 1380347-84-1 tert-butyl 3-(1-benzyl-3-nitro-1H-pyrazol-4-yl)-N-(diphenylmethylene)-L-alaninate 
• 1380347-82-9 1-benzyl-4-(bromomethyl)-3-nitro-1H-pyrazole 
• 1380347-81-8 (1-benzyl-3-nitro-1H-pyrazol-4-yl)methanol 
• 1428734-00-2 C₁₁H₉N₃O₄ 
• 1224256-32-9 C₁₈H₁₅N₅ 

Relevant articles and documents

AZOLOPYRIDINE AND AZOLOPYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF

Provided herein are azolopyridine and azolopyrimidine compounds for treatment of JAK kinase mediated diseases, including JAK2 kinase-, JAK3 kinase- or TYK2 kinase-mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions.

Adenosine A3 receptor modulators

The compounds of the following formula: wherein R, R2, R3 and A have the meanings given in the specification, are endowed with selective A3 adenosine receptor antagonist activity. These compounds can be used in a pharmaceu

Adenosine A3 receptor modulators

The compounds of the following formula: wherein R, R2, R3 and A have the meanings given in the specification, are endowed with selective A3 adenosine receptor antagonist activity. These compounds can be used in a pharmaceu